STOCK TITAN

Kaya Holdings (KAYS) Stock Price, News & Analysis

KAYS OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
77 156 sessions, November 3, 2025 to November 3, 2026
Largest daily move
+1200% close of October 1, 2026
1-year change
-97.2% closing prices, November 3, 2025 to November 3, 2026
1-month change
+0% closing prices, October 2, 2026 to November 3, 2026

Company Description

Kaya Holdings, Inc. (OTCQB: KAYS) is a fully reporting, US-based publicly traded company that describes itself as a "mind care" company. According to its public disclosures, Kaya Holdings has operations in the emerging psilocybin treatment sector and in medical/recreational cannabis, and is developing activities related to digital assets and cryptocurrency through a new subsidiary and a proposed Digital Assets Treasury (DAT) strategy.

Business Focus and Operating Segments

Kaya Holdings states that it has operations in the psilocybin treatment sector through its majority owned subsidiary Fifth Dimension Therapeutics, Inc. (FDT). FDT serves as the company’s operating branch in the psychedelic treatment sector, including operation of mushroom cultivation facilities and The Sacred Mushroom™ psilocybin treatment centers. The company reports that The Sacred Mushroom is a licensed psilocybin treatment center in Portland, Oregon, authorized by the Oregon Health Authority to administer psilocybin treatments within the state regulatory framework.

In addition to psychedelics, Kaya Holdings reports historical and ongoing involvement in medical and recreational cannabis. The company states that in 2014 it became the first US public company to own and operate a medical cannabis dispensary in Portland, Oregon, under the Kaya Shack™ brand. It further discloses interests in three cannabis licenses, with one license in Portland, Oregon, and two in Greece, and references cannabis-related activities through subsidiaries such as Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., and Kaya Brands USA, Inc.

The Sacred Mushroom™ Psilocybin Treatment Center

Through FDT, Kaya Holdings operates The Sacred Mushroom psilocybin treatment center in Portland, Oregon. The company’s news releases describe The Sacred Mushroom as a legally licensed psilocybin treatment center authorized by the Oregon Health Authority to administer psilocybin treatments. The facility is described as occupying approximately 11,000 square feet on the top floor of a historic building in downtown Portland, offering private treatment rooms, group session areas, an indoor garden, and activity zones for yoga, listening stations, journaling, art expression, and other journey-enhancing activities.

The company highlights a proprietary experience framework called "Synergy by Design", which is presented as allowing guests to customize aspects of their psilocybin sessions, including space, sound, scent, and activities such as creative expression and mind-body practices. Kaya Holdings’ disclosures emphasize that The Sacred Mushroom is intended to provide a curated setting for psilocybin experiences in accordance with Oregon’s psilocybin regulations.

Cannabis Operations and International Footprint

Kaya Holdings reports that it continues to be involved in cannabis through several subsidiaries. Marijuana Holdings Americas, Inc. is described as owning the Kaya Shack brand of licensed medical and recreational marijuana stores and the Kaya Farms™ brand of cannabis production and processing operations in the United States. Kaya Brands International, Inc. is presented as the vehicle for non-U.S. operations, including cultivation activities under development in Greece and Israel. Kaya Brands USA, Inc. is reported to own proprietary brands of cannabis extracts, oils, pre-rolls, topicals, edibles and beverages, cannaceuticals and related accessories.

The company’s disclosures indicate that it has interests in three cannabis licenses, one in Portland, Oregon, and two in Greece, and that it has sought to shift portions of its cannabis operations to serve the European Union through its international subsidiaries.

Digital Assets and Cryptocurrency Strategy

In more recent communications, Kaya Holdings has described plans to develop a cryptocurrency operating subsidiary and pursue a Digital Assets Treasury (DAT) strategy. The company has announced that it engaged Greentree Financial Group, Inc. and Conduit Advisors, LLC to assist with the development of this subsidiary and related cryptocurrency operations. According to its press releases and related Form 8-K filings, Kaya Holdings and its advisors are reviewing potential plans to enter the cryptocurrency industry, including possibilities such as licensed cryptocurrency custody and trading services in the United States, Grand Cayman and other jurisdictions, and collaborations with cryptocurrency foundations, for-profit companies and Decentralized Autonomous Organizations.

The company has also stated that it is exploring a joint venture with one or more cryptocurrencies, with a focus on candidates among the top cryptocurrencies by market capitalization and potential alignment with networks such as Solana, Ethereum or Polygon. Kaya Holdings presents the DAT concept as a way to hold yield-generating digital assets on its balance sheet and has indicated that it views its public company status as a potential platform for implementing this strategy.

Capital Structure and Change in Control

According to a Form 8-K filed in October 2025, Kaya Holdings entered into debt reduction and debt conversion agreements with various debt holders, converting a substantial portion of its outstanding debt into equity. The filing reports that the company issued shares of common stock in satisfaction of debt obligations, including a significant issuance to CVC International Ltd., which has been described as a principal source of capital for the company since 2014. As a result of these conversions, the filing states that CVC now holds a majority of the voting power of the company’s capital stock, and that a change in control of the company is deemed to have taken place.

Regulatory Status and Reporting

Kaya Holdings identifies itself as a fully reporting company under the US securities laws, with its common stock listed for trading on the OTCQB market under the symbol KAYS. The company files periodic and current reports with the US Securities and Exchange Commission, including Forms 10-Q, 10-K, and 8-K. A Form 12b-25 notification of late filing indicates that the company has, at times, required additional time to complete financial statements and file quarterly reports, while stating its intention to file within the permitted extension period.

In its public communications, Kaya Holdings repeatedly notes that its business plans in psychedelics and cannabis are subject to state and local laws and to federal enforcement policies and priorities. The company cautions that advice of counsel, potential federal, state or local legal actions, and changes in government policy or law may affect its operations and shareholder value. It also notes that certain initiatives, such as the launch and expansion of The Sacred Mushroom psilocybin treatment center and the implementation of its digital assets strategy, are dependent on factors such as licensing, financing, capital structure adjustments and other conditions.

Summary

Overall, Kaya Holdings, Inc. presents itself as a diversified "mind care" holding company focused on regulated psilocybin treatment services, cannabis-related operations in the United States and abroad, and an emerging strategic focus on digital assets and cryptocurrency through a planned Digital Assets Treasury model. Its activities span licensed psilocybin service delivery in Oregon, branded cannabis retail and production, international cannabis cultivation projects, and exploratory work in digital asset treasuries, all within the framework of US public company reporting and applicable regulatory regimes.

Stock Performance

$0.0013
+0.00%
+0.0000
Last updated: November 3, 2026 at 16:00
-97.2%
Performance 1 year
$892.4K

Kaya Holdings (KAYS) closed at $0.0013 on November 3, 2026. Over the past 12 months, the price has lost 97.2%.

See what a $1,000 investment in KAYS would be worth today

Average down calculator for KAYS

KAYS Metrics & Rankings

Price returns through November 3, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Kaya Holdings has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include crypto, fda approval. View all KAYS news →

SEC Filings

Kaya Holdings has filed 6 recent SEC filings, including 3 Form 8-K, 1 Form NT 10-K, 1 Form 10-Q, 1 Form NT 10-Q. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KAYS SEC filings →

Financial Highlights

Kaya Holdings generated $7K in revenue in FY2024, retaining a -5.1% gross margin. Diluted earnings per share stood at -$0.07. The company generated -$831K in operating cash flow. The current ratio was 0.01, measuring current assets divided by current liabilities.

$7K
Revenue (FY2024)
-$831K
Operating Cash Flow
-$366
Gross Profit (FY2024)

Upcoming Events

No upcoming events scheduled for KAYS.

KAYS Company Profile & Sector Positioning

Kaya Holdings (KAYS) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing KAYS often look at related companies in the same sector, including TransGlobal Assets Inc (TMSH), CBD of Denver Inc (CBDD), CannaPharmaRX Inc (CPMD), Software EFF Sltns Corp (SFWJ), and Sibannac Inc (SNNC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KAYS's relative position within its industry.

Frequently Asked Questions

The current stock price of Kaya Holdings (KAYS) is $0.0013 as of November 3, 2026.

The market cap of Kaya Holdings (KAYS) is approximately $892.4K. Learn more about what market capitalization means .

The FY2024 revenue of Kaya Holdings (KAYS) is $7K, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Kaya Holdings (KAYS) is -$0.07 for FY2024, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Kaya Holdings (KAYS) is -$831K for FY2024, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Kaya Holdings (KAYS) is -5.1% for FY2024, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Kaya Holdings (KAYS), current assets divided by current liabilities, was 0.01 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Kaya Holdings (KAYS) is -$366 for FY2024, its most recent completed fiscal year.

Kaya Holdings, Inc. describes itself as a mind care company with operations in the emerging psilocybin treatment sector and in medical/recreational cannabis. Through subsidiaries, it operates The Sacred Mushroom psilocybin treatment center in Portland, Oregon, holds interests in cannabis licenses in Oregon and Greece, and is developing a digital assets treasury and cryptocurrency-focused subsidiary.

Kaya Holdings, Inc. states that it is a fully reporting, US-based publicly traded company listed for trading on the OTCQB market under the symbol KAYS.

Kaya Holdings reports that it has medical and recreational cannabis operations through subsidiaries. It states that it became the first US public company to own and operate a medical cannabis dispensary in Portland, Oregon under the Kaya Shack brand, has interests in three cannabis licenses in Oregon and Greece, and operates cannabis-related brands and cultivation or processing activities through entities such as Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., and Kaya Brands USA, Inc.

Kaya Holdings has announced plans to develop a cryptocurrency operating subsidiary and pursue a Digital Assets Treasury strategy. According to its press releases and related SEC filings, the company is working with Greentree Financial Group and Conduit Advisors to explore cryptocurrency-related operations and potential joint ventures with established cryptocurrencies, with the goal of holding yield-generating digital assets on its balance sheet.

Fifth Dimension Therapeutics, Inc. is described by Kaya Holdings as its operating branch in the psychedelic treatment sector. It is responsible for mushroom cultivation facilities and the operation of The Sacred Mushroom psilocybin treatment centers, and serves as the vehicle for the company’s psilocybin-related activities.

A Form 8-K filed in October 2025 reports that Kaya Holdings entered into debt reduction and debt conversion agreements that resulted in the issuance of common stock to various debt holders, including CVC International Ltd. The filing states that CVC now holds a majority of the voting power of the company’s capital stock and that a change in control of the company is deemed to have taken place.

In its public communications, Kaya Holdings notes that its plans in psychedelics and cannabis depend on state and local laws and on federal enforcement policies and priorities. It cautions that legal advice, potential government actions, and changes in laws or policies may affect its business operations and shareholder value, and it highlights that certain projects depend on licensing, financing and other conditions.

Kaya Holdings mentions operations and facilities in Portland, Oregon, and references activities or licenses in Greece and Israel through its subsidiaries. It also notes historical and advisory connections to Grand Cayman in relation to its planned cryptocurrency and digital assets activities.

Kaya Holdings’ news releases frequently invite shareholders and other interested parties to contact the company, update their contact information, and request operational updates. The company provides email contact details in those releases and indicates that it responds to inquiries from stockholders and other stakeholders.